BioNxt Solutions signs terms for new precision drug coating platform technology

VANCOUVER, BC / ACCESSWIRE / December 12, 2022 / BioNxt Solutions Inc. (“BioNxt” or “Society“) (CSE:XPHY)(OTC:XPHYF)(FSE:4XT) is pleased to announce that it has signed a non-binding term sheet (“Term Sheet”) to acquire certain intellectual property assets and rights related to new technology to deliver coatings for solid oral dosage form of the drug (“Technology”). The …

BioNxt Solutions signs terms for new precision drug coating platform technology Read More »